Breaking News

MPI Research Executive to Serve as ACT President

Serota brings 34 years of toxicology expertise

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

David Serota, Ph.D., DABT, MPI Research’s senior vice president of drug safety development and senior principal study director, will serve as the 2012 American College of Toxicology (ACT) president. Dr. Serota has been a member of ACT since 1981 and has served on the membership committee, served as councilor, vice president, and president-elect. During his role as vice president he chaired the awards committee, and most recently chaired the program committee as president-elect. Dr. Serota has h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters